4.7 Article

Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19

Related references

Note: Only part of the references are listed.
News Item Medicine, General & Internal

COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?

Rita Rubin

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Infectious Diseases

Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study

Eric J. Haas et al.

Summary: The nationwide vaccination campaign in Israel has successfully prevented a large number of SARS-CoV-2 infections, hospitalizations, and deaths, especially among individuals aged 65 years and older. The full vaccination of the population has played a significant role in controlling the pandemic.

LANCET INFECTIOUS DISEASES (2022)

Article Cardiac & Cardiovascular Systems

Impact ofCOVID-19 pandemic onSTEMIcare: An expanded analysis from the United States

Santiago Garcia et al.

Summary: The COVID-19 pandemic mitigation measures have led to a significant decrease in activations for STEMI care, angiography, and PPCI. Additionally, there has been an increase in average D2B times, indicating a negative impact on timely access to cardiac catheterization laboratories for PPCI.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2021)

Article Medicine, General & Internal

Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction

Marwan Saad et al.

Summary: Limited research was conducted on patients with ST-segment elevation myocardial infarction (STEMI) and COVID-19. This study compared characteristics, treatment, and outcomes of patients with STEMI with vs without COVID-19 infection. The results showed that having a concomitant diagnosis of COVID-19 was significantly associated with higher rates of in-hospital mortality among patients with out-of-hospital or in-hospital STEMI compared with patients without a diagnosis of COVID-19 from the past year.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

TCT-63 North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital Mortality

Payam Dehghani et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Medicine, General & Internal

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

Ronen Arbel et al.

Summary: Among 843,208 participants in Israel aged 50 years or older who had received two doses of the BNT162b2 vaccine at least 5 months earlier, those who received a booster had 90% lower mortality due to Covid-19 than those who did not receive a booster during the 54-day study period.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Critical Care Medicine

Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data

Annakan V. Navaratnam et al.

Summary: This study analyzed hospitalized adult patients with COVID-19 in England from March to May 2020, identifying factors such as age, sex, deprivation index, ethnicity, comorbidities, and discharge date that were associated with in-hospital mortality. The study found that in-hospital mortality for COVID-19 patients decreased over time, possibly due to changes in hospital strategies and clinical processes.

LANCET RESPIRATORY MEDICINE (2021)

Article Public, Environmental & Occupational Health

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Cardiac & Cardiovascular Systems

International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19

Thomas A. F. Kite et al.

Summary: This study aimed to report the demographics, angiographic findings, and in-hospital outcomes of COVID-19 ACS patients and compare them with pre-COVID-19 cohorts. The study found that COVID-19-positive ACS patients experienced delayed presentation and had higher in-hospital mortality rates compared to the control subjects before the COVID-19 pandemic. Excessive rates of and mortality from cardiogenic shock were major contributors to the worse outcomes in COVID-19 positive STEMI patients.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Initial Findings From the North American COVID-19 Myocardial Infarction Registry

Santiago Garcia et al.

Summary: The NACMI registry study describes the characteristics and outcomes of COVID-19 patients with STEMI, indicating that COVID+ patients have unique situations in treatment and prognosis.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

Giuseppe De Luca et al.

Summary: The study reveals that among STEMI patients undergoing PPCI, those who are SARS-CoV-2 positive have a higher mortality rate, higher incidence of in-stent thrombosis, and are more likely to have culprit lesions in the right coronary artery compared to SARS-CoV-2 negative patients.

ATHEROSCLEROSIS (2021)

Letter Medicine, General & Internal

Trends in Mortality From COVID-19 and Other Leading Causes of Death Among Latino vs White Individuals in Los Angeles County, 2011-2020

Paul Simon et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients: A Self-Controlled Case Series Analysis of a Nationwide Cohort

Frederick K. Ho et al.

Summary: Confirmed COVID-19 infection was associated with early elevations in risk of MI and ischemic stroke, and substantially stronger and prolonged elevations in risk of DVT and PE, both in hospital and community settings. Thromboembolism, especially PE, should be considered among people with COVID-19 in the community.

MAYO CLINIC PROCEEDINGS (2021)

Article Medicine, General & Internal

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Alejandro Jara et al.

Summary: A study in Chile involving 10.2 million participants assessed the effectiveness of an inactivated SARS-CoV-2 vaccine developed in China. Fully immunized individuals had vaccine effectiveness of 65.9% for preventing Covid-19 and 87.5% for preventing hospitalization, 90.3% for preventing ICU admission, and 86.3% for preventing death.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

S. J. Thomas et al.

Summary: BNT162b2 vaccine remains highly effective and safe over the course of 6 months post-vaccination, with efficacy rates ranging from 86% to 100% across different demographics and risk factors for Covid-19. The vaccine also shows a high efficacy against severe disease, with particularly promising results observed in South Africa against the B.1.351 variant.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

The Midwest ST-Elevation Myocardial Infarction Consortium: Design and Rationale

Mehmet Yildiz et al.

Summary: The development of regional STEMI care systems over the past 20 years has led to progress in achieving timely coronary reperfusion and improved clinical outcomes, but there is still room for improvement. The Midwest STEMI Consortium was established as a collaboration of 4 large regional STEMI care systems to provide a comprehensive, multicenter, and prospective STEMI registry without exclusionary criteria. This collaboration offers a unique platform for conducting clinical research studies to optimize STEMI care, particularly for high-risk STEMI subsets like CA and/or CS.

CARDIOVASCULAR REVASCULARIZATION MEDICINE (2021)

Article Medicine, General & Internal

Trends in COVID-19 Risk-Adjusted Mortality Rates

Leora Horwitz et al.

Summary: A study in a three-hospital academic health system in New York showed a decrease in hospital mortality rates among COVID-19 patients, with adjusted mortality dropping from 25.6% in March to 7.6% in August. The standardized mortality ratio also decreased from 1.26 in March to 0.38 in August, indicating an improving trend in patient outcomes. These findings suggest that mortality from COVID-19 may be decreasing even after adjusting for patient characteristics.

JOURNAL OF HOSPITAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications

Payam Dehghani et al.

AMERICAN HEART JOURNAL (2020)

Letter Cardiac & Cardiovascular Systems

ST-Elevation Myocardial Infarction in Patients With COVID-19 Clinical and Angiographic Outcomes

Giulio G. Stefanini et al.

CIRCULATION (2020)

Editorial Material Cardiac & Cardiovascular Systems

Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era Business as Usual?

Matthew J. Daniels et al.

CIRCULATION (2020)

Letter Medicine, General & Internal

ST-Segment Elevation in Patients with Covid-19-A Case Series

Sripal Bangalore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Cardiac & Cardiovascular Systems

Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic

Santiago Garcia et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China

Dingcheng Xiang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Editorial Material Critical Care Medicine

Trends in COVID-19-related in-hospital mortality: lessons learned from nationwide samples Comment

Purnema Madahar et al.

LANCET RESPIRATORY MEDICINE (2020)